Literature DB >> 30081073

Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.

Lindsey E Roeker1, Haesook T Kim2, Brett Glotzbecker3, Prashant Nageshwar3, Sarah Nikiforow3, John Koreth3, Philippe Armand3, Corey Cutler3, Edwin P Alyea3, Joseph H Antin3, Paul G Richardson3, Robert J Soiffer3, Vincent T Ho4.   

Abstract

Hepatic veno-occlusive disease (VOD), or sinusoidal obstruction syndrome (SOS), is a serious complication of hematopoietic stem cell transplantation (HSCT) with mortality in its severe form exceeding 80%. Although the incidence of VOD/SOS has fallen with contemporary transplantation practices, the increasing use of inotuzumab, the return of gemtuzumab, and the popularity of pharmacokinetic-guided high-dose busulfan may impact incidence. Early intervention with defibrotide improves survival, but prompt diagnosis can be difficult. We aimed to identify clinical parameters that could aid in early detection of VOD/SOS in a large, retrospective, cohort study. Of the 1823 adult patients who underwent myeloablative HSCT between 1996 and 2015 in our center, 205 (11%) developed VOD/SOS, with a median onset of day +14. We compared parameters in the 7 days preceding VOD/SOS onset for cases to 447 randomly selected control subjects in an analogous time frame to determine those with predictive value. Between 7 days before and the day of diagnosis, VOD/SOS patients had higher serum creatinine levels and were more likely to develop acute kidney injury (61% versus 33%, P < .0001), more commonly experienced refractoriness to platelet transfusion (48% versus 24%, P < .0001), and had higher trough serum tacrolimus levels (7 days before VOD/SOS onset: median 8.8 versus 7.3, P = .0002; day of onset: median 9.3 versus 7.2, P < .0001) compared with control subjects. Acute renal dysfunction, platelet refractoriness, and elevated or abnormal tacrolimus levels are dynamic clinical markers that should alert clinicians to the development of VOD/SOS before the presence of classical diagnostic criteria. Using these clinical features to recognize VOD/SOS earlier in its clinical course could promote earlier treatment and lead to improved outcomes of this potentially serious complication.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Defibrotide; SOS; Sinusoidal obstruction syndrome; Tacrolimus; VOD; Veno-occlusive disease

Mesh:

Substances:

Year:  2018        PMID: 30081073     DOI: 10.1016/j.bbmt.2018.07.039

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  6 in total

Review 1.  Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.

Authors:  Mitchell S Cairo; Kenneth R Cooke; Hillard M Lazarus; Nelson Chao
Journal:  Br J Haematol       Date:  2020-03-04       Impact factor: 6.998

2.  Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant.

Authors:  Mary Nauffal; Haesook T Kim; Paul G Richardson; Robert J Soiffer; Joseph H Antin; Corey Cutler; Sarah Nikiforow; Mahasweta Gooptu; John Koreth; Rizwan Romee; Vincent T Ho
Journal:  Blood Adv       Date:  2022-01-11

3.  Incidence and Risk Factors for Acute Kidney Injury after Allogeneic Stem Cell Transplantation: A Prospective Study.

Authors:  Andreea Andronesi; Bogdan Sorohan; Andreea Burcea; Lavinia Lipan; Cristina Stanescu; Oana Craciun; Laura Stefan; Adela Ranete; Zsofia Varady; Oana Ungureanu; Gabriela Lupusoru; Gabriela Agrigoroaei; Danut Andronesi; Luminita Iliuta; Bogdan Obrisca; Alina Tanase
Journal:  Biomedicines       Date:  2022-01-25

4.  Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia.

Authors:  Federico Ravaioli; Giovanni Marconi; Giovanni Martinelli; Elton Dajti; Chiara Sartor; Maria Chiara Abbenante; Luigina Vanessa Alemanni; Jacopo Nanni; Benedetta Rossini; Sarah Parisi; Luigi Colecchia; Gianluca Cristiano; Giovanni Marasco; Amanda Vestito; Stefania Paolini; Francesca Bonifazi; Antonio Curti; Davide Festi; Michele Cavo; Antonio Colecchia; Cristina Papayannidis
Journal:  Cancer Med       Date:  2021-12-30       Impact factor: 4.452

Review 5.  Early diagnostic value of liver stiffness measurement in hepatic sinusoidal obstruction syndrome induced by hematopoietic stem cell transplantation.

Authors:  You-Wen Tan; Yi-Chun Shi
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

Review 6.  Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?

Authors:  Giuseppe Lia; Luisa Giaccone; Sarah Leone; Benedetto Bruno
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.